ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q1SCImago #7,956Hybrid

Medical Mycology

Acronym:tmmy
•
Abbreviation (ISO):MED. MYCOL
•
Identifier (ISSN):1369-3786(Print)/1460-2709(Online)
•
Publisher:Oxford University Press
Clarivate IF (2026)
3.5↑ +1.2
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Medical Mycology

WoS Q2
13462.820182.8520192.8220204.0820213.7520222.920232.720242.320253.52026
Annual Impact Factor Metric
Current (2026):3.5
Scopus SJR & RankScopus Q1
0.721
#7,956

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
115

115 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate7.4%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
145articles/year
18.48% Gold OA•95.24% Original Research

Aims & Scope

Medical Mycology is a peer-reviewed international journal that focuses on original and innovative basic and applied studies, as well as learned reviews on all aspects of medical, veterinary and environmental mycology as related to disease. The objective is to present the highest quality scientific reports from throughout the world on divergent topics. These topics include the phylogeny of fungal pathogens, epidemiology and public health mycology themes, new approaches in the diagnosis and treatment of mycoses including clinical trials and guidelines, pharmacology and antifungal susceptibilities, changes in taxonomy, description of new or unusual fungi associated with human or animal disease, immunology of fungal infections, vaccinology for prevention of fungal infections, pathogenesis and virulence, and the molecular biology of pathogenic fungi in vitro and in vivo, including genomics, transcriptomics, metabolomics, and proteomics. Case reports are no longer accepted. In addition, studies of natural products showing inhibitory activity against pathogenic fungi are not accepted without chemical characterization and identification of the compounds responsible for the inhibitory activity.

Topics Covered (Recognized by AI)
Biology93%Medicine86.3%Microbiology78.9%Genetics72%Chemistry59.9%Biochemistry54.1%Botany54.1%Immunology49.7%Dermatology49.5%Pathology43.7%Internal medicine39.2%Antifungal36.6%Geology35.8%Paleontology35.1%Gene24.6%Surgery21.2%Organic chemistry21%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

INFECTIOUS DISEASES

Q2
Rank48/141
IndexSCIE
JCRSCIE2026

MYCOLOGY

Q2
Rank13/33
IndexSCIE
JCRSCIE2026

VETERINARY SCIENCES

Q1
Rank12/170
IndexSCIE
JCISCIE2026

INFECTIOUS DISEASES

Q2
Rank36/141
IndexSCIE
JCISCIE2026

MYCOLOGY

Q2
Rank9/33
IndexSCIE
JCISCIE2026

VETERINARY SCIENCES

Q1
Rank41/170
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF3.5
Articles / Year105
Total Citations19
2025
IF2.3
Articles / Year127
Total Citations279
2024
IF2.7
Articles / Year132
Total Citations1,087
2023
IF2.9
Articles / Year129
Total Citations1,196
2022
IF3.747
Articles / Year647
Total Citations1,211

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #7,956Scopus Q1SCImago Profile
Scopus Coverage:1962-2026
Scopus Broad Areas:MedicineVeterinary
Scopus Citation Rank (SJR)Q1
0.721

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
3.16

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,103 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,116
3-Year Documents370
Citable Documents366

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate51.5%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Veterinary (miscellaneous)Q1
Infectious DiseasesQ2
Medicine (miscellaneous)Q2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 7.4%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区INFECTIOUS DISEASES
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Medical Mycology (acronym: tmmy, abbr: MED. MYCOL, ISSN: 1369-3786) is a peer-reviewed international scholarly journal in the field of Medicine, published by Oxford University Press in England since 1998. The periodical holds a Journal Impact Factor (JIF) of 3.50, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.721 (Q1), an H-index of 115.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 145 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,103 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Oxford University Press
Publication Language
English
Frequency
Bimonthly
Founding Year
1998
Indexing & Databases
SCIEScopusPubMed
Editorial Address
TAYLOR & FRANCIS LTD, 4 PARK SQUARE, MILTON PARK, ABINGDON, ENGLAND, OXON, OX14 4RN

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 9feb5aa3-d04f-4e82-aaa5-8f0fc62859ef
Database Updated: 2026-10-01